TC Biopharm (Holdings) Plc (TCBP)

NASDAQ: TCBP · Real-Time Price · USD

0.379

-0.006 (-1.58%)

At close: Jan 17, 2025, 4:00 PM

0.376

-0.003 (-0.77%)

Pre-market: Jan 21, 2025, 5:46 AM EST

TC Biopharm (Holdings) Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	1	2.46	4.81	1.57	0.75	0.96
Cash & Short-Term Investments	1	2.46	4.81	1.57	0.75	0.96
Cash Growth	-47.65%	-48.78%	206.89%	109.45%	-21.80%	-
Accounts Receivable	-	-	-	-	-	0.11
Other Receivables	1.26	1.1	1.78	1.41	1.18	2.91
Receivables	1.26	1.1	1.78	1.41	1.18	3.02
Prepaid Expenses	0.46	0.83	0.84	0.81	0.23	0.24
Other Current Assets	1.23	1.31	0.03	0.07	0.05	0
Total Current Assets	3.95	5.7	7.45	3.86	2.22	4.22
Property, Plant & Equipment	2.31	2.62	3.29	3.68	4.63	5.61
Other Intangible Assets	0.61	0.62	0.55	0.48	0.42	0.31
Total Assets	6.87	8.93	11.29	8.02	7.27	10.14
Accounts Payable	0.94	1.85	0.88	1.42	0.64	0.63
Accrued Expenses	2.09	2.41	0.94	2.33	0.92	0.48
Short-Term Debt	-	-	0.65	13.73	-	-
Current Portion of Leases	0.31	0.31	0.33	0.77	0.44	0.41
Current Income Taxes Payable	0.18	0.14	0.29	0.31	0.14	0.27
Current Unearned Revenue	-	-	-	1.98	1.98	2.03
Other Current Liabilities	0	0.05	6.06	0.04	0.06	0.06
Total Current Liabilities	3.53	4.75	9.16	20.58	4.19	3.88
Long-Term Leases	1.34	1.5	1.8	2.14	2.58	3.02
Long-Term Unearned Revenue	-	-	-	1.87	3.84	5.77
Total Liabilities	4.87	6.25	10.96	24.58	10.61	12.68
Common Stock	0.41	0.4	0.4	0.2	0.19	1.78
Additional Paid-In Capital	45.74	41.12	33.31	-	-	11.1
Retained Earnings	-44.15	-38.84	-33.37	-33.47	-19.89	-15.42
Comprehensive Income & Other	-	-	-	16.71	16.35	-
Shareholders' Equity	2	2.69	0.33	-16.56	-3.35	-2.54
Total Liabilities & Equity	6.87	8.93	11.29	8.02	7.27	10.14
Total Debt	1.65	1.8	2.78	16.63	3.03	3.44
Net Cash (Debt)	-0.65	0.66	2.03	-15.07	-2.28	-2.48
Net Cash Growth	-	-67.41%	-	-	-	-
Net Cash Per Share	-3.50	21.41	-	-	-	-
Filing Date Shares Outstanding	0.49	0.32	0.01	0.01	0.01	-
Total Common Shares Outstanding	0.49	0.1	-	0.01	0.01	-
Working Capital	0.42	0.95	-1.72	-16.72	-1.97	0.34
Book Value Per Share	4.05	26.11	-	-1583.99	-334.51	-
Tangible Book Value	1.4	2.07	-0.22	-17.04	-3.77	-2.85
Tangible Book Value Per Share	2.83	20.13	-	-1630.25	-376.86	-
Machinery	0.45	0.45	0.43	0.42	0.41	0.4

Source: S&P Capital IQ. Standard template. Financial Sources.